Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Soldatos

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|February 10, 2022
Advancing drug safety science by integrating molecular knowledge with post-marketing adverse event reportsTheodoros G Soldatos, Sarah Kim, Stephan Schmidt, et al.
Diagnostics (Basel, Switzerland)|November 3, 2018
Retrospective Side Effect Profiling of the Metastatic Melanoma Combination Therapy Ipilimumab-Nivolumab Using Adverse Event DataTheodoros G Soldatos, Antonia Dimitrakopoulou-Strauss, Lionel Larribere, et al.
BMC Pregnancy and Childbirth|December 13, 2022
Exploring the acceptability and experience of receiving diabetes and pregnancy care via telehealth during the COVID-19 pandemic: a qualitative studyS L Kozica-Olenski, G Soldatos, L Marlow, et al.
Methods (San Diego, Calif.)|August 5, 2014
How to learn about gene function: text-mining or ontologies?Theodoros G Soldatos, Nelson Perdigão, Nigel P Brown, et al.
BMC Systems Biology|December 2, 2008
Arena3D: visualization of biological networks in 3DGeorgios A Pavlopoulos, Seán I O'Donoghue, Venkata P Satagopam, et al.
Clinical Pharmacology and Therapeutics|October 22, 2020
Target Adverse Event Profiles for Predictive Safety in the Postmarket SettingPeter Schotland, Rebecca Racz, David B Jackson, et al.
Clinical and Translational Science|February 22, 2022
Application of a patient-centered reverse translational systems-based approach to understand mechanisms of an adverse drug reaction of immune checkpoint inhibitorsSarah Kim, Gezim Lahu, Majid Vakilynejad, et al.
Journal of Diabetes and Its Complications|June 13, 2020
The association of smoking status with glycemic control, metabolic profile and diabetic complications- Results of the Australian National Diabetes Audit (ANDA)N Szwarcbard, M Villani, A Earnest, et al.
Clinical and Translational Science|January 11, 2022
A case study of a patient-centered reverse translational systems-based approach to understand adverse event profiles in drug developmentSarah Kim, Gezim Lahu, Majid Vakilynejad, et al.
Cancers|April 25, 2020
Public Adverse Event Data Insights into the Safety of Pembrolizumab in Melanoma PatientsAnne Schaefer, Christos Sachpekidis, Francesca Diella, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
CPT: Pharmacometrics & Systems Pharmacology|February 10, 2022
Advancing drug safety science by integrating molecular knowledge with post-marketing adverse event reportsTheodoros G Soldatos, Sarah Kim, Stephan Schmidt, et al.
Diagnostics (Basel, Switzerland)|November 3, 2018
Retrospective Side Effect Profiling of the Metastatic Melanoma Combination Therapy Ipilimumab-Nivolumab Using Adverse Event DataTheodoros G Soldatos, Antonia Dimitrakopoulou-Strauss, Lionel Larribere, et al.
BMC Pregnancy and Childbirth|December 13, 2022
Exploring the acceptability and experience of receiving diabetes and pregnancy care via telehealth during the COVID-19 pandemic: a qualitative studyS L Kozica-Olenski, G Soldatos, L Marlow, et al.
Methods (San Diego, Calif.)|August 5, 2014
How to learn about gene function: text-mining or ontologies?Theodoros G Soldatos, Nelson Perdigão, Nigel P Brown, et al.
BMC Systems Biology|December 2, 2008
Arena3D: visualization of biological networks in 3DGeorgios A Pavlopoulos, Seán I O'Donoghue, Venkata P Satagopam, et al.
Clinical Pharmacology and Therapeutics|October 22, 2020
Target Adverse Event Profiles for Predictive Safety in the Postmarket SettingPeter Schotland, Rebecca Racz, David B Jackson, et al.
Clinical and Translational Science|February 22, 2022
Application of a patient-centered reverse translational systems-based approach to understand mechanisms of an adverse drug reaction of immune checkpoint inhibitorsSarah Kim, Gezim Lahu, Majid Vakilynejad, et al.
Journal of Diabetes and Its Complications|June 13, 2020
The association of smoking status with glycemic control, metabolic profile and diabetic complications- Results of the Australian National Diabetes Audit (ANDA)N Szwarcbard, M Villani, A Earnest, et al.
Clinical and Translational Science|January 11, 2022
A case study of a patient-centered reverse translational systems-based approach to understand adverse event profiles in drug developmentSarah Kim, Gezim Lahu, Majid Vakilynejad, et al.
Cancers|April 25, 2020
Public Adverse Event Data Insights into the Safety of Pembrolizumab in Melanoma PatientsAnne Schaefer, Christos Sachpekidis, Francesca Diella, et al.
Pageof 4